Proteomic analysis of holocarboxylase synthetase deficient-MDA-MB-231 breast cancer cells revealed the biochemical changes associated with cell death impaired growth signaling and metabolism

Abstract

We have previously shown that the holocarboxylase synthetase (HLCS) is overexpressed in breast cancer tissue of patients and silencing of its expression in triple-negative cancer cell line inhibits growth and migration. Here we investigated the global biochemical changes associated with HLCS knockdown in MDA-MB-231 cells to discern the pathways that involve HLCS. Proteomic analysis of two independent HLCS knockdown cell lines identified 347 differentially expressed proteins (DEPs) whose expression change > 2-fold (p < 0.05) relative to the control cell line. GO enrichment analysis showed that these DEPs were mainly associated with the cellular process such as cellular metabolic process cellular response to stimulus and cellular component organization or biogenesis metabolic process biological regulation response to stimuli localization and signaling. Among the 347 identified DEPs 64 proteins were commonly found in both HLCS knockdown clones confirming their authenticity. Validation of some of these DEPs by Western blot analysis showed that plasminogen activator inhibitor type 2 (SerpinB2) and interstitial collagenase (MMP1) were approximately 90% decreased in HLCS knockdown cells consistent with a 50%�% decrease in invasion ability of knockdown cells. Notably argininosuccinate synthase 1 (ASS1) one of the enzymes in the urea cycle showed approximately a 10-fold increase in the knockdown cells suggesting the crucial role of HLCS in supporting the urea cycle in the triple-negative cancer cell line. Collectively our proteomic data provide biochemical insights into how suppression of HLCS expression perturbs global changes in cellular processes and metabolic pathways impairing cell growth and invasion. Copyright ? 2024 Sukjoi Young Acland Siritutsoontorn Roytrakul Klingler-Hoffmann Hoffmann and Jitrapakdee.